Post by account_disabled on Jan 2, 2024 4:15:23 GMT
Ready to enter the new era economy Cooperate with all sectors to develop biotechnology businesses. After finding that the Thai modern medicine market is worth 180 billion baht, growing continuously at 6.5% per year, it is found that "biological medicines" are growing rapidly at 16-19%, showing signs of increasing the proportion from 30% to 50% in 5-10 years. Mr. Marut Buranasetthakul Chief Executive Officer of Bio Genetech International Company Limited (BGIC), a biotechnology business developer. (Biotechnology) about biopharmaceuticals (Biopharmaceutical Products) and others revealed that BGIC sees opportunities and benefits that will occur to the country's biotechnology-based pharmaceutical manufacturing industry that will enable Thailand to step into the new economy.
We have made a memorandum of B2B Email List understanding with leading educational institutions to cooperate to support Promote research and develop biopharmaceutical products Aiming to be a leader in the development of this industry in the country. In 2018, the global modern medicine market was valued at 24 trillion baht, growing at 6.5%. The drugs with high growth and popularity are biologics. Its growth rate was as high as 13%, while in Asia it grew at 19%, higher than the overall growth rate. It is also likely to continue to grow.
As for the overall market of Thailand, it is worth approximately 180 billion baht, growing approximately 6.5%, with the majority still being the synthetic chemical drug market, approximately 70%, all of which are imported both in the form of raw materials for production in the country and Imported in ready-made medicine form But it was found that biological drugs accounted for 30%, growing as high as 16-19% and likely to account for no less than 50% within 5-10 years. It is expected that Thailand will be able to make and produce biopharmaceuticals. from research within the country itself in the near future Mr. Marut further said that BGIC has organized a management system for various projects.
We have made a memorandum of B2B Email List understanding with leading educational institutions to cooperate to support Promote research and develop biopharmaceutical products Aiming to be a leader in the development of this industry in the country. In 2018, the global modern medicine market was valued at 24 trillion baht, growing at 6.5%. The drugs with high growth and popularity are biologics. Its growth rate was as high as 13%, while in Asia it grew at 19%, higher than the overall growth rate. It is also likely to continue to grow.
As for the overall market of Thailand, it is worth approximately 180 billion baht, growing approximately 6.5%, with the majority still being the synthetic chemical drug market, approximately 70%, all of which are imported both in the form of raw materials for production in the country and Imported in ready-made medicine form But it was found that biological drugs accounted for 30%, growing as high as 16-19% and likely to account for no less than 50% within 5-10 years. It is expected that Thailand will be able to make and produce biopharmaceuticals. from research within the country itself in the near future Mr. Marut further said that BGIC has organized a management system for various projects.